手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| Morisky Medication Adherence Scale(MMAS)× | 臨床的フレイル・スケール(CFS)× | |
|---|---|---|
| 分野 | 看護学 | 看護学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1986 | 2005 |
| 提唱者≠ | Donald E. Morisky | Kenneth Rockwood |
| 種類≠ | Patient self-report questionnaire | Clinician-rated frailty assessment |
| 原典≠ | Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care, 24(1), 67-74. DOI ↗ | Rockwood, K., Song, X., MacKnight, C., et al. (2005). A global clinical measure of fitness and frailty in elderly people. CMAJ, 173(5), 489-495. DOI ↗ |
| 別名 | MMAS, Morisky Scale, Medication Adherence Scale | CFS, Frailty Scale, Clinical Frailty Assessment |
| 関連≠ | 2 | 3 |
| 概要≠ | The Morisky Medication Adherence Scale is a brief, validated tool developed by Donald Morisky in 1986 to measure patients' adherence to prescribed medications. Originally created to assess hypertension medication compliance, it has since become a standard screening instrument across chronic disease management, primary care, and pharmaceutical research. The scale is valued for its brevity, ease of administration, and predictive validity for clinical outcomes. | The Clinical Frailty Scale (CFS), developed by Kenneth Rockwood and colleagues in 2005, is a brief, validated tool for assessing frailty in older adults. Frailty—a syndrome of diminished physiologic reserve, increased vulnerability, and reduced functional ability—is recognized as a distinct clinical state that predicts mortality, disability, and healthcare utilization independent of age and comorbidities. The CFS uses a seven-point (or nine-point in later versions) clinical judgment-based scale, making it practical and rapid for bedside use in hospitals, clinics, and long-term care. |
| ScholarGateデータセット ↗ |
|
|